A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Metastatic|Pancreatic Cancer|NSCLC, Metastatic|Synovial Sarcoma|Colon Cancer|Metastatic Colon Cancer|Melanoma Recurrent|Metastatic Skin Cancer|Melanoma Stage IV|Triple Negative Breast Cancer|TNBC - Triple-Negative Breast Cancer|Cholangiocarcinoma|Ovarian Cancer|Metastatic Melanoma|Hepatocellular Carcinoma
Interventions: DRUG: ST316
Sponsor: Sapience Therapeutics